BioFire BCID2 Diagnostic Panels Recalled for Temperature-Related Performance Issues
BioFire Diagnostics is recalling BioFire BCID2 diagnostic panels that experienced temperature excursions during shipment, which may reduce their performance. Affected kits were distributed in Florida and Georgia.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or deaths. The hazard is reduced diagnostic performance from temperature exposure, which is potential rather than manifested in actual harm.
Plain-English summary
BioFire Diagnostics, LLC is recalling the BioFire BCID2 Panel, an in vitro diagnostic test kit used in clinical laboratories. The recall was initiated because products were stored outside their required temperature specifications during shipment, a result of shipping delays.
Temperature excursions can reduce the diagnostic performance of the affected test panels. This condition may affect the accuracy or reliability of test results produced by these kits.
The affected products were distributed nationwide to healthcare facilities in Florida and Georgia. No illnesses or injuries have been reported in connection with this recall.
Healthcare providers and laboratories that received affected products should discontinue use and contact BioFire Diagnostics for replacement products and additional guidance.
The recalled product
- Product
- In Vitro Diagnostic (IVD) Panel BioFire BCID2 Panel - REF RFIT-ASY-0147
- Manufacturer
- BioFire Diagnostics, LLC
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Part Number: RFIT-ASY-0147 UDI: 0815381020338 Pouch Lot Number: 1766022
Distribution
Part of a larger recall action
This product is one of 3 recalled by BioFire Diagnostics, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · BioFire Diagnostics, LLC
See all →- HighBioFire Respiratory Panel 2.1 Recalled for Increased False Negative Results
FDA (Devices) · 2026-08-19
- HighBioFire Joint Infection Panel diagnostic test kit contamination recall
FDA (Devices) · 2026-05-13
- HighBioFire Spotfire Respiratory/Sore Throat Panel Recall for False Negatives
FDA (Devices) · 2026-05-13
- HighRespiratory test panels recalled over elevated risk of false negative results
FDA (Devices) · 2025-12-03
- HighBioFire Respiratory Panel 2.1 plus Kit recalled for manufacturing defect
FDA (Devices) · 2025-06-04
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30